Literature DB >> 28554190

23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility.

Julia Wynn1, Wendy K Chung1.   

Abstract

Mesh：

Year:  2017        PMID： 28554190     DOI： 10.7326/M17-1045

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.

Authors:  Melanie W Hardy; Beth N Peshkin; Esther Rose; Mary Kathleen Ladd; Savannah Binion; Mara Tynan; Colleen M McBride; Karen A Grinzaid; Marc D Schwartz
Journal:  J Community Genet       Date:  2022-04-29

2.  Consumer genomics will change your life, whether you get tested or not.

Authors:  Razib Khan; David Mittelman
Journal:  Genome Biol       Date:  2018-08-20       Impact factor: 13.583

3.  False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.

Authors:  Stephany Tandy-Connor; Jenna Guiltinan; Kate Krempely; Holly LaDuca; Patrick Reineke; Stephanie Gutierrez; Phillip Gray; Brigette Tippin Davis
Journal:  Genet Med       Date:  2018-03-22       Impact factor: 8.822
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.